VIMFLUITY
Live / Allowed — Fifth extension granted (statement of use) (as of 22 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Sept 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97604606
- Mark type
- Word mark
- Filed
- 23 Sept 2022
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 22 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2026 — SOU EXTENSION 5 GRANTED
- 29 Jun 2026 — SOU EXTENSION 5 FILED
- 21 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 12 May 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 May 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 May 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 May 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Dec 2025 — SOU EXTENSION 4 GRANTED